hotspot -WSS

hotspot

author：comprehensive 2025-09-28 21:57:07 - browse：457

Miniature people figurines standing in a group looking down. -- health tech coverage from STAT — Adobe

In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Why drug prescriptions should include diagnoses

focus

entertainment

WSS

Death of patient in Alzheimer’s trial raises question of possible risks

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

CDC concerned about possible undetected monkeypox spread in U.K.

Why we need to separate burnout from moral injury in health care

DeepMind touts AlphaFold's new skills as protein folding AI models face off

All of Us, NIH's precision medicine initiative, gets a big boost

focus

hotspot

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

Medicare must police algorithms in Medicare Advantage, Dems say

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Brain injuries and the importance of a second opinion

Anesthesiologist group: stop taking Ozempic before surgery

Bill would allow buprenorphine prescription for addiction via telehealth

Medicare details structure of new drug price negotiation program

How to convince healthy people to buy insurance

Walensky prepares to leave CDC — and Congress — behind

Donald Trump's relentless attacks on special counsel Jack Smith

Wikipedia

3 hurdles to bringing medical devices to the U.S. market

Weight bias in eating disorder treatment complicated by new weight loss drugs

How neuroscience research could help beat back brain cancer

Do masks work? RCTs can't tell us

3 hurdles to bringing medical devices to the U.S. market

Why drug prescriptions should include diagnoses

focus

explore

entertainment

explore